Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : India Coffee House -- Ignore unavailable to you. Want to Upgrade?

To: Mohan Marette who wrote (5754)	8/20/1999 11:24:00 PM
From: Mohan Marette	Respond to of 12475

Operation Vijay - Kargil update They died for the country nic.in vijayinkargil.org 'Under the cover of night'-TIME magazine pathfinder.com Contributions received by the 'army welfare fund' from the public. armedforces.nic.in

To: Mohan Marette who wrote (5754)	8/20/1999 11:39:00 PM
From: Mohan Marette	Read Replies (1) \| Respond to of 12475

Maruti targets a turnover of Rs 10,000 Cr (US$ 2.3 billion) by 2000-01. Maruti Udyog Ltd marutiudyog.com Maruti Countrywide Credit (A GE Capital Company) maruticountrywide.com MUL targets a turnover of Rs 10,000 cr by 2000-01 Our New Delhi Bureau (Financial Express) 20 AUGUST MARUTI Udyog Limited (MUL), the country's largest car manufacturer, will become a Rs 10,000-crore (US$ 2.3 billion) car major by the end of the financial year, 2000-2001. Mr Jagdish Khattar, who recently took over as MUL's sole managing director, while addressing his first press conference said, the company would be generating this revenue on a production base of about 500,000 cars. "The company would be posting a turnover of about Rs 9,000 crore (US$2.01 billion) by the end of the current financial year, but we have a target plan of being a Rs 10,000 crore company by the end of financial year 2000," said Mr Khattar. The profitability of the company, he said however, would take a beating as the company had decided to absorb the cost of its upgraded cars, and also because of various investments undertaken by MUL to expand its manufacturing capacity. "Automobile companies have to take a long term view of the market and plan their move accordingly. At Maruti, we have decided to absorb all costs of upgradation and concentrate on volumes," said the MD. On MUL?s strategy in the market place, he said Maruti would have a car in each market segment and Maruti-800 would continue to be the entry level car for consumers. Mr Khattar, however, refused to give any details of the new launches planned. "World-wide, major car companies like GM in the US and Toyota in Japan enjoy a market share of about 27 per cent and 40 per cent respectively. Maruti will continue to be a dominant player in the car sector and we hope to maintain a market share of over 50 per cent in India," said Mr Khattar. On the issue of Euro-II, Mr Khattar said, the government is yet to notify the Indian equivalent of Euro-II. "We would comply with the Euro-II norms before the specified date but the government has yet to issue a notification of the Indian equivalent of Euro-II," claimed Mr Khattar. Giving statistics, Mr Khattar stated, Maruti has recorded a 15.7 per cent growth rate in its passenger car segment during the first four months of the current financial year as against an industry growth of 36.8 per cent in the passenger car segment. "Despite the entry of several new entrants in the Zen car segment, market share of Zen continues to be the highest at 36 per cent," said Mr Khattar, who added that the relationship between the joint venture partners was `cordial?, with the company going ahead with its expansion and new launches on schedule.

To: Mohan Marette who wrote (5754)	8/23/1999 9:32:00 AM
From: Mohan Marette	Respond to of 12475

India allows Pfizer set up 100 pct subsidiary NEW DELHI, Aug 23 (Reuters) - India's Foreign Investment Promotion Board on Monday approved a proposal of Pfizer Inc (NYSE:PFE - news) to set up a wholly owned subsidiary to manufacture new drugs in the country, an Industry Ministry official said. ``The company will manufacture five new drugs in India.This will be a completely new venture of the foreign drug multinational,' the official who did not wish to be identified said. biz.yahoo.com